Filing Details

Accession Number:
0001104659-14-056481
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-04 18:38:59
Reporting Period:
2014-08-01
Filing Date:
2014-08-04
Accepted Time:
2014-08-04 18:38:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410939 Ophthotech Corp. OPHT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1228459 Bruce Peacock C/o Ophthotech Corporation
One Penn Plaza, 19Th Floor
New York NY 10119
Cfo & Cbo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-08-01 6,191 $1.65 6,191 No 4 M Direct
Common Stock Disposition 2014-08-01 6,091 $37.77 100 No 4 S Direct
Common Stock Disposition 2014-08-01 100 $38.55 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right To Buy) Disposition 2014-08-01 6,191 $0.00 6,191 $1.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
28,025 2020-09-27 No 4 M Direct
Footnotes
  1. The exercise of options and sales of common stock reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2013.
  2. These shares were disposed of in multiple transactions on August 1, 2014 at actual sales prices ranging from $37.53 to $38.50 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. This option was granted on September 28, 2010 and is currently exercisable for all shares underlying the option.